Frequency of Extra-Intestinal Manifestations of Ulcerative Colitis in Patients Presenting in A Tertiary Care Hospital

Authors

  • Maria Hussain Department of Medicine, Shalamar Hospital, Lahore, Pakistan
  • Saqib Rashid Department of Medicine, Shalamar Hospital, Lahore, Pakistan
  • Ramza Aqib Department of Medicine, Shalamar Hospital, Lahore, Pakistan
  • Haroon Yousaf Department of Medicine, Shalamar Hospital, Lahore, Pakistan
  • Haroon Javaid Department of Medicine, GMC Teaching Hospital, Gujranwala, Pakistan
  • Shanza Ijaz Department of Medicine, GMC Teaching Hospital, Gujranwala, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i6.1826

Keywords:

Ulcerative Colitis, Extra-Intestinal Manifestations, Inflammatory Bowel Disease

Abstract

Ulcerative Colitis (UC) is a chronic inflammatory bowel disease primarily affecting the colon and rectum. However, a significant proportion of patients also experience extra-intestinal manifestations (EIMs), which may involve the musculoskeletal, dermatological, ocular, and hepatobiliary systems. These manifestations can complicate the clinical course and significantly impact the patient's quality of life. Objective: To determine the frequency and distribution of extra-intestinal manifestations in patients with UC presenting at a tertiary care hospital and assess associations with demographic and clinical factors. Methods: This cross-sectional study was conducted over three months from January to March 2025, at the Department of Medicine, Shalamar Hospital, Lahore. A total of 125 patients with a confirmed diagnosis of UC were enrolled using non-probability consecutive sampling. Data were collected through a structured proforma, with confirmation of EIMs by relevant specialists. Statistical analysis was performed using SPSS version 23. Chi-square and t-tests were applied to assess associations, with a p-value < 0.05 considered significant. Results: Out of 125 patients, 47 (37.6%) exhibited extra-intestinal manifestations. Musculoskeletal involvement was the most common (25.6%), followed by dermatological (12.0%), hepatobiliary (11.2%), and ocular (10.4%) manifestations. A statistically significant association was observed between longer disease duration and the presence of EIMs (mean duration: 8.2 ± 2.4 years vs. 5.6 ± 2.1 years, p = 0.0004). No significant gender difference was found, although musculoskeletal symptoms were more common in males and dermatological conditions were more frequent in females. Conclusion: EIMs are a common and clinically significant aspect of UC, affecting over one-third of patients in this study. The findings highlight the importance of early recognition and multidisciplinary management of EIMs, particularly in patients with longer disease duration. Routine screening and inter-specialty coordination can facilitate timely diagnosis and enhance patient outcomes. Further multicenter longitudinal studies are warranted to explore the long-term impact and progression of EIMs in diverse populations.

Downloads

Download data is not yet available.

References

Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, et. al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014 Dec 1420(46):17463-7. https://doi.org/10.3748/wjg.v20.i46.17463

Malik TF, Aurelio DM. Extraintestinal Manifestations of Inflammatory Bowel Disease. [Updated 2023 Mar 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Janhttps://www.ncbi.nlm.nih.gov/books/NBK568797

Guillo L, D'Amico F, Serrero M, Angioi K, Loeuille D, Costanzo A, Danese S, Peyrin-Biroulet L. Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials. United European Gastroenterol J. 2020 Nov;8(9):1013-1030. https://doi.org/10.1177/2050640620950093

Baumgart, D.C., Cheng, C.H., Du, T.X. et al. Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn’s disease and ulcerative colitis. npj Digit. Med. 8, 209 (2025). https://doi.org/10.1038/s41746-025-01504-6

Rawal KK, Shukla VP, Chikani S, Thakkar M, Ruparelia M, Chudasama RK. Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors. Indian J Gastroenterol. 2021 Oct;40(5):477-482.ihttps://doi.org/10.1007/s12664-021-01181-9

Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, et. al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011 Jan; 106 (1):110-9. https://doi.org/10.1038/ajg.2010.343

Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et. al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016 Mar 10 (3):239-54. https://doi.org/0.1093/ecco-jcc/jjv213

Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002 Sep 123 (3):714-8. doi: https://doi.org/10.1053/gast.2002.35396

Hedin CRH, Vavricka SR, Stagg AJ, Schoepfer A, Raine T, Puig L, Pleyer U, et.al. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. J Crohns Colitis. 2019 Apr 2613(5):541-554. doi: https://doi.org/10.1093/ecco-jcc/jjy191

Siddiqui AA, Bashir B, Ansari MA, Jabeen R, Ahrned S, Khashoob MB. Extraintestinal manifestations of ulcerative colitis in the Omani population: A study of 100 cases. J Liaquat Univ Med Heal Sci. 20098(1):8-11.

Ali U, Jahangir Anjum SA, Erum H, Hamid S, Mir NA. Demographic Profile and Extra-Intestinal Manifestations of Ulcerative Colitis in the Pakistani population. PJMHS 2023 Mar 517(01):559. https://doi.org/10.53350/pjmhs2023171559

Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, et.al. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015 Mar50(3):300-5. https://doi.org/10.3109/00365521.2014.991752

Alizadeh M, Motwani K, Siaton BC, Abutaleb A, Ravel J, Cross RK; SPARC-IBD Investigators. Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD. Inflamm Bowel Dis. 2024 Nov 4;30(11):2027-2036. https://doi.org/10.1093/ibd/izad280n

1. Biancardi AL, Zaltman C, Troncoso LL, Luiz RR, Moraes HV de. The Role of Clinical-Demographic Characteristics in Ophthalmic Manifestations of Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2018 May 11;25(3):e15–6. https://doi.org/10.1093/ibd/izy159

- Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021 Oct;161(4):1118-1132. https://doi.org/10.1053/j.gastro.2021.07.042

- Hernández-Tejero M, Granja Navacerrada A, Bernal Checa P, Piqué Becerra R, Algaba García A, Guerra Marina I, García-Alonso FJ, Syed M, Bermejo F. Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease. Rev Esp Enferm Dig. 2017 Sep;109(9):627-633. https://doi.org/10.17235/reed.2017.4845/2017

- Rahim H, Shah IA, Zill-E Huma Mustehsan, Nadeem K, Kumar N, Khokhar A. Prevalence of Extra Intestinal Manifestations in Inflammatory Bowel Disease and Associated Risk Factors. 2021 Dec 30;15(12):3935–8. https://doi.org/10.53350/pjmhs2115123935

- Bourikas LA, Papadakis KA. Musculoskeletal manifestations of inflammatory bowel disease. Inflammatory bowel diseases. 2009;15(12):1915-1924. doi: https://doi.org/10.1002/ibd.20942

- Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021 Oct;161(4):1118-1132. https://doi.org/10.1053/j.gastro.2021.07.042

- Faggiani I, Fanizza J, D'Amico F, Allocca M, Zilli A, Parigi TL, Barchi A, Danese S, Furfaro F. Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment. Biomedicines. 2024 Aug 13;12(8):1839. https://doi.org/10.3390/biomedicines12081839

Downloads

Published

2025-06-30

How to Cite

Hussain, M. ., Rashid, S. ., Aqib, R. ., Yousaf, H. ., Javaid, H. ., & Ijaz, S. . (2025). Frequency of Extra-Intestinal Manifestations of Ulcerative Colitis in Patients Presenting in A Tertiary Care Hospital. Biological and Clinical Sciences Research Journal, 6(6), 91–95. https://doi.org/10.54112/bcsrj.v6i6.1826

Issue

Section

Original Research Articles